A groundbreaking advancement in the realm of nanomedicine has been achieved by the Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo’s São Carlos Institute of Physics (IFSC-USP) in Brazil. The group has successfully engineered hydroxyapatite nanoparticles augmented with intrinsic luminescent properties through the incorporation of carbonate groups. This breakthrough opens novel avenues in biomedical imaging, presenting a biocompatible and cost-effective alternative to conventional imaging agents.
Hydroxyapatite, a bioceramic material naturally found in bone and teeth, has long captivated researchers due to its excellent biocompatibility and bioactivity. Typically employed in bone grafts and dental implants, its luminescent potential has remained largely untapped. The GNano team, however, demonstrated that by strategically integrating carbonate ions into the crystal lattice of hydroxyapatite, they could manipulate the concentration of lattice defects, which act as luminescent centers, thus significantly enhancing the material’s intrinsic photoluminescence.
This enhancement is rooted in defect chemistry: carbonate substitution increases structural vacancies and point defects within the crystalline hydroxyapatite matrix. These defects facilitate radiative recombination processes that yield stronger and more stable light emission. The researchers further functionalized these nanoparticles with citrate groups to improve their colloidal stability in aqueous environments, a crucial step to ensure effective cellular internalization and bioimaging utility.
In cellular experiments, the luminescent hydroxyapatite nanoparticles were visualized penetrating cells by utilizing confocal fluorescence microscopy solely dependent on their intrinsic luminescence. The precise cellular uptake was corroborated by flow cytometry analyses, reinforcing the potential of these nanoparticles as reliable bioimaging probes. Importantly, viability assays confirmed their biocompatibility, indicating no significant cytotoxic effect on the tested cell lines.
Beyond imaging capabilities, the study holds promise for expanding hydroxyapatite applications into photocatalysis and spectroscopic evaluations of hard tissues. Manipulating defect profiles and luminescence characteristics in carbonated hydroxyapatite may allow development of novel photocatalytic materials for environmental remediation and provide sophisticated spectroscopic tools for analyzing biological hard tissues such as bones and teeth.
Parallel to these efforts, GNano and the Center for Molecular Engineering of Advanced Materials (CEMol) forged a pioneering drug delivery platform utilizing calcium phosphate nanoparticles for targeted chemotherapy. Using gemcitabine, a potent chemotherapeutic agent, they crafted a dual pH-responsive nanoparticle system that remains inert under normal physiological pH but activates drug release specifically within acidic tumor microenvironments, such as pancreatic cancers.
This innovative release mechanism effectively safeguards the drug from premature deactivation in the systemic circulation and ensures maximum therapeutic efficacy upon reaching acidic tumor sites. Additionally, surface functionalization with folic acid endows the nanoparticles with active targeting capabilities, exploiting the high folate receptor density on many cancer cells, thereby enhancing selective tumor uptake and minimizing off-target side effects.
The formulation begins with gemcitabine conjugated to carboxymethylcellulose, a biocompatible polymer that enhances drug stability and enables the acid-triggered release profile. This same polymer also ensures the colloidal stability of calcium phosphate nanoparticles, preventing aggregation and maintaining dispersion in biological fluid environments. The marriage of controlled release, pH-responsiveness, and ligand-mediated targeting epitomizes a sophisticated and safer cancer treatment modality.
These developments not only underscore the potential of nanostructured calcium phosphate materials in oncology but also signal a substantial stride towards precision nanomedicine. The combination of biocompatibility inherent to calcium phosphate and multifunctional targeting strategies could revolutionize chemotherapy by reducing necessary doses and attenuating deleterious impacts on healthy tissues, vastly improving patient quality of life.
Overall, the GNano group has laid the cornerstone for a new generation of nanotechnologies that integrate advanced imaging and therapeutic functions within biologically inert and safe materials. Their research sets the stage for future exploration of luminescent scaffolds in tissue engineering, environmentally friendly photocatalysts, and highly selective drug delivery vehicles.
This research exemplifies the transformative power of defect chemistry and material engineering in the design of functional nanomaterials. By tailoring intrinsic luminescence through carbonate incorporation and leveraging polymeric functionalization for stability and drug conjugation, the team demonstrates a holistic approach to solving critical challenges in biomedical imaging and cancer therapy.
The findings were detailed in a peer-reviewed publication appearing in the journal ACS Nanoscience Au and highlight a synergistic collaboration between academic institutions and research centers dedicated to innovation in molecular and materials engineering. The study not only elucidates fundamental aspects of hydroxyapatite photoluminescence but also pioneers practical solutions for pressing medical challenges.
As the scientific community continues to push boundaries in nanomedicine, such versatile calcium phosphate nanoparticles are poised to become cornerstones of next-generation diagnostics and therapeutics. Their affordability, safety, and multifunctionality make them prime candidates for widespread adoption and further clinical translation.
Subject of Research: Nanostructured hydroxyapatite nanoparticles with enhanced luminescence properties for biomedical imaging; pH-responsive, folate-targeted calcium phosphate nanoparticles for controlled chemotherapy drug delivery.
Article Title: Defect-Related Photoluminescence in Hydroxyapatite Nanoparticles Modulated by Carbonate Incorporation
News Publication Date: 18-Dec-2025
Web References:
Publication: ACS Nanoscience Au
Nanomedicine Group: GNano IFSC-USP
Center for Molecular Engineering: CEMol
FAPESP website: www.fapesp.br/en
References:
Machado, T.R., et al. “Defect-Related Photoluminescence in Hydroxyapatite Nanoparticles Modulated by Carbonate Incorporation.” ACS Nanoscience Au, 2025.
Parallel study on chemotherapy delivery published in ACS Applied Bio Materials.
Keywords: Biomedical imaging, Hydroxyapatite nanoparticles, Luminescence, Carbonate incorporation, Nanomedicine, pH-responsive drug delivery, Calcium phosphate, Gemcitabine, Cancer treatment, Targeted therapy, Photocatalysis, Tissue engineering
Tags: bioactive materials for bone graftsbiocompatible imaging agentscarbonate group substitution in bioceramicscellular internalization of luminescent nanoparticlescitrate-functionalized nanoparticles for stabilitycost-effective alternatives to conventional imagingdefect chemistry for enhanced photoluminescencehydroxyapatite nanoparticles for biomedical imagingintrinsic luminescent properties in nanomedicinenanomedicine breakthroughs in cancer treatmentnanotoxicology in cancer therapySão Carlos Institute of Physics nanotechnology research
